TABLE. Clinical profile of leprosy patients.
| Patient | Sex | Age | BI at admission | Leprosy cases / investigated household contacts * | Treatment (months) | Intercurrence | BI after 12 months of treatment | Reactional episode after cure |
| 1 | M | 38 | 5 | 0/4 | R/C/D (0-12) | No | 1.75 | Yes |
| 2 | M | 44 | 5 | 0/3 | R/C/D (0-12) | No | 3.75 | Yes |
| 3 | F | 56 | 5.5 | 0/11 | R/C/D (0-12) | No | 4.75 | Yes |
| 4 | F | 40 | 5.75 | 1/2 | R/C/D (0-12) | No | 4.75 | Yes |
| 5 | M | 62 | 4 | 0/3 | NT (0-4) R/C/O (4-12) | Pneumonia / Hemolytic anaemia | 4 | Yes |
| 6 | M | 41 | 4 | 0/4 | R/C/D (0-12) | No | 2.5 | No |
| 7 | F | 12 | 5 | 2/4 | R/C/D (0-12) | No | 4.75 | Yes |
| 8 | M | 54 | 4.75 | 0/11 | R/C/O (0-12) | No | 2.3 | Yes |
| 9 | F | 20 | 5 | 1/20 | R/C/D (0-2) NT (2-4) R/C/O (4-12) | Dapsone sensitivity / Hemolytic anaemia | 4.85 | Yes |
| 10 | M | 33 | 5.25 | 1/11 | R/C/D (0-12) | No | 3.7 | Yes |
M: male; F: female; BI: bacilloscopic index; R/C/D: rifampicin, clofazimine, and dapsone (conventional treatment); R/C/O: rifampicin, clofazimine, and ofloxacine (alternative treatment); NT: not treated; *all household contacts leprosy cases were diagnosed as multibacillary.